ACADIA Pharmaceuticals Inc
F:DR6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ACADIA Pharmaceuticals Inc
F:DR6
|
US |
|
B
|
Berkshire Hathaway Inc
XHAM:BRH
|
US |
|
C
|
Credit Agricole SA
XMUN:XCA
|
FR |
|
Fastenal Co
NASDAQ:FAST
|
US |
|
A
|
ADT Inc
SWB:541
|
US |
|
S
|
Schneider Electric SE
F:SND
|
FR |
|
DSV A/S
F:DS81
|
DK |
|
Singapore Telecommunications Ltd
SGX:Z74
|
SG |
|
U
|
United Parcel Service Inc
XBER:UPAB
|
US |
Wall St Price Targets
DR6 Price Targets Summary
ACADIA Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for DR6 is 25.78 EUR with a low forecast of 13.19 EUR and a high forecast of 36.31 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DR6's stock price target?
Price Target
25.78
EUR
According to Wall Street analysts, the average 1-year price target for DR6 is 25.78 EUR with a low forecast of 13.19 EUR and a high forecast of 36.31 EUR.
What is the Revenue forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Gross Profit forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Gross Profit over the next 8 years is 9%.
What is the Operating Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
27%
The compound annual growth rate for Operating Income over the next 8 years is 27%.
What is the Pre-Tax Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
34%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 34%.
What is the Net Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Net Income over the next 8 years is 9%.
